Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash And Cash Equivalents
$901 Mil (As of Mar. 2014)

Teva Pharmaceutical Industries Ltd's quarterly cash and cash equivalents declined from Sep. 2013 ($1,148 Mil) to Dec. 2013 ($1,038 Mil) and declined from Dec. 2013 ($1,038 Mil) to Mar. 2014 ($901 Mil).

Teva Pharmaceutical Industries Ltd's annual cash and cash equivalents increased from Dec. 2011 ($1,096 Mil) to Dec. 2012 ($2,879 Mil) but then declined from Dec. 2012 ($2,879 Mil) to Dec. 2013 ($1,038 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 7841,2761,3321,4881,8541,9951,2481,0962,8791,038

Teva Pharmaceutical Industries Ltd Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
BS_CashAndCashEquivalents 1,0961,0621,1881,4322,8791,3941,2451,1481,038901
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide